Nomura Holdings’s ResMed RMD Stock Holding History

Nomura Holdings’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.08M	Hold	4,800	–	–	﹤0.01%	1134
2025 Q4	$1.16M	Hold	4,800	–	–	﹤0.01%	1281
2025 Q3	$1.31M	Buy	+4,800	New	+$1.31M	﹤0.01%	1305

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nomura Holdings's RMD Position: Q1 2026 in Review

Nomura Holdings increased its ResMed (RMD) stake by 47% in Q1 2026, buying an estimated $2.93M and bringing the position to 36,993 shares worth $8.3M. The position accounts for 0.02% of the portfolio, ranked #472.

Nomura Holdings first reported a position in RMD in Q2 2013 and has held it in 32 quarters since. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Nomura Holdings held 36,993 shares of ResMed worth $8.3M as of Q1 2026.
Nomura Holdings bought 11,753 ResMed shares in Q1 2026, an estimated $2.93M.
ResMed made up 0.02% of Nomura Holdings's portfolio in Q1 2026, its #472 holding.
Nomura Holdings first reported a position in ResMed in Q2 2013 and has held it in 32 quarters since.
939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.